Pisciotta L, Ossoli A, Ronca A, Garuti A, Fresa R, Favari E, Calabresi L, Calandra S, Bertolini S (2022)
Plasma HDL pattern, cholesterol efflux and cholesterol loading capacity of serum in carriers of a novel missense variant (Gly176Trp) of endothelial lipase
J Clin Lipidol
Gomaraschi M, Fracanzani AL, Dongiovanni P, Pavanello C, Giorgio E, Da Dalt L, Norata GD, Calabresi L, Consonni D, Lombardi R, Branchi A, Fargion S (2019)
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures
Biochimica & Biophysica Acta Molecular & Cellular Biology Lipids 1864: 158523
Pavanello C, Baragetti A, Branchi A, Grigore L, Castelnuovo S, Giorgio E, Catapano AL, Calabresi L, Gomaraschi M (2019)
Treatment with fibrates is associated with higher LAL activity in dyslipidemic patients
Pharmacol Res
Freeman LA, Demosky SJ, Jr., Konaklieva M, Kuskovsky R, Aponte A, Ossoli AF, Gordon SM, Koby RF, Manthei KA, Shen M, Vaisman BL, Shamburek RD, Jadhav A, Calabresi L, Gucek M, Tesmer JJG, Levine RL, Remaley AT (2017)
Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31
Journal of Pharmacology & Experimental Therapeutics 362: 306
Gomaraschi M, Ossoli A, Castelnuovo S, Simonelli S, Pavanello C, Balzarotti G, Arca M, Di Costanzo A, Sampietro T, Vaudo G, Baldassarre D, Veglia F, Franceschini G, Calabresi L (2017)
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency
J Lipid Res 58: 994
Lucca F, Ossoli A, Boscutti G, Franceschini G, Calabresi L (2016)
[Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy]
G Ital Nefrol 33:
Ossoli A, Neufeld EB, Thacker SG, Vaisman B, Pryor M, Freeman LA, Brantner CA, Baranova I, Francone NO, Demosky SJ, Jr., Vitali C, Locatelli M, Abbate M, Zoja C, Franceschini G, Calabresi L, Remaley AT (2016)
Lipoprotein X Causes Renal Disease in LCAT Deficiency
PLoS ONE 11: e0150083
Manzini S, Pinna C, Busnelli M, Cinquanta P, Rigamonti E, Ganzetti GS, Dellera F, Sala A, Calabresi L, Franceschini G, Parolini C, Chiesa G (2015)
Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice
Vascul Pharmacol 74: 114
Zimetti F, Favari E, Cagliero P, Adorni MP, Ronda N, Bonardi R, Gomaraschi M, Calabresi L, Bernini F, Guardamagna O (2015)
Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease
Atherosclerosis 242: 443
Sensi C, Simonelli S, Zanotti I, Tedeschi G, Lusardi G, Franceschini G, Calabresi L, Eberini I (2014)
Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays
PLoS ONE 9: e95044
Simonelli S, Tinti C, Salvini L, Tinti L, Ossoli A, Vitali C, Sousa V, Orsini G, Nolli ML, Franceschini G, Calabresi L (2013)
Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency
Biologicals 41: 446
Calabresi L, Simonelli S, Gomaraschi M, Franceschini G (2012)
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease
Atherosclerosis 222: 299
Conca P, Pileggi S, Simonelli S, Boer E, Boscutti G, Magnolo L, Tarugi P, Penco S, Franceschini G, Calabresi L, Gomaraschi M (2012)
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia
J Clin Lipidol 6: 244
Boscutti G, Calabresi L, Pizzolitto S, Boer E, Bosco M, Mattei PL, Martone M, Milutinovic N, Berbecar D, Beltram E, Franceschini G (2011)
[LCAT deficiency: a nephrological diagnosis]
G Ital Nefrol 28: 369
Charlton-Menys V, Pisciotta L, Durrington PN, Neary R, Short CD, Calabresi L, Calandra S, Bertolini S (2007)
Molecular characterization of two patients with severe LCAT deficiency
Nephrol Dial Transplant 22: 2379
Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, Alessandrini P, Arca M, Bon GB, Boscutti G, Busnach G, Frasca G, Gesualdo L, Gigante M, Lupattelli G, Montali A, Pizzolitto S, Rabbone I, Rolleri M, Ruotolo G, Sampietro T, Sessa A, Vaudo G, Cantafora A, Veglia F, Calandra S, Bertolini S, Franceschini G (2005)
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families
Arterioscler Thromb Vasc Biol 25: 1972
Calabresi L, Villa B, Canavesi M, Sirtori CR, James RW, Bernini F, Franceschini G (2004)
An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia
Metabolism 53: 153
Frasca GM, Soverini L, Tampieri E, Franceschini G, Calabresi L, Pisciotta L, Preda P, Vangelista A, Stefoni S, Bertolini S (2004)
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene
Nephrol Dial Transplant 19: 1622
Deakin S, Leviev I, Gomaraschi M, Calabresi L, Franceschini G, James RW (2002)
Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism
Journal of Biological Chemistry 277: 4301
Sessa A, Battini G, Meroni M, Daidone G, Carnera I, Brambilla PL, Vigano G, Giordano F, Pallotti F, Torri Tarelli L, Calabresi L, Rolleri M, Bertolini S (2001)
Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations
Nephron 88: 268
James RW, Blatter Garin MC, Calabresi L, Miccoli R, von Eckardstein A, Tilly-Kiesi M, Taskinen MR, Assmann G, Franceschini G (1998)
Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states
Atherosclerosis 139: 77